BIOL – biolase inc (US:NASDAQ)
Stock Stats
News
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form 8-K BIOLASE, INC For: Sep 30
Form 8-K BIOLASE, INC For: Aug 31
Form 25-NSE BIOLASE, INC Filed by: Nasdaq Stock Market LLC
Form 8-K BIOLASE, INC For: Aug 28
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.